by jlohrconsulting | Nov 11, 2025 | Uncategorized
Trends Psychiatry Psychother. 2025 Nov 10. doi: 10.47626/2237-6089-2025-1127. Online ahead of print. ABSTRACT OBJECTIVE: Cognitive-behavioral therapy (CBT) is a first-line treatment for anxiety and depressive disorders, but its preventive efficacy remains uncertain....
by jlohrconsulting | Nov 11, 2025 | Uncategorized
J Long Term Eff Med Implants. 2025;35(4):69-77. doi: 10.1615/JLongTermEffMedImplants.2025056315. ABSTRACT The current study sought to assess the impact on quality of life in individuals with a single posterior tooth loss, as well as its improvement after a single-unit...
by jlohrconsulting | Nov 11, 2025 | Uncategorized
Nutr Neurosci. 2025 Nov 10:1-11. doi: 10.1080/1028415X.2025.2587076. Online ahead of print. ABSTRACT BACKGROUND: Recent research highlights the central role of emotion in psychopathology, with Panksepp’s Affective Neuroscience Theory identifying seven primary...
by jlohrconsulting | Nov 11, 2025 | Uncategorized
JAMA Netw Open. 2025 Nov 3;8(11):e2534304. doi: 10.1001/jamanetworkopen.2025.34304. ABSTRACT IMPORTANCE: Long COVID presents an unmet therapeutic need. OBJECTIVE: To determine the effects of a resistance exercise intervention on exercise capacity, health status, and...
by jlohrconsulting | Nov 11, 2025 | Uncategorized
Aging Dis. 2025 Nov 5. doi: 10.14336/AD.2025.1075. Online ahead of print. ABSTRACT Major depressive disorder (MDD) affects hundreds of millions worldwide and remains a major unmet clinical need because conventional monoaminergic agents achieve remission in fewer than...
by jlohrconsulting | Nov 11, 2025 | Uncategorized
Aging Dis. 2025 Nov 5. doi: 10.14336/AD.2025.1075. Online ahead of print. ABSTRACT Major depressive disorder (MDD) affects hundreds of millions worldwide and remains a major unmet clinical need because conventional monoaminergic agents achieve remission in fewer than...
Recent Comments